Discussing the management using the algorithm of HER 2 Neu Positive Breast Cancer – with Dr. Erika Hamilton, Director of Breast & Gynecologic Cancer Research, Sarah Cannon Research Institute.
Tags:
Related Posts
AlgorithmsNET2025October 02, 2025
Exploring the role of targeted radiopharmaceutical treatment in NETs
AlgorithmsMelanoma2025September 25, 2025